Gross Margin
4.40%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 1.69%.Updated Oct 22, 2026Profit Margin
-6.47%vs Specialty Chemicals peers Updated Oct 22, 2026Operating Margin
-5.56%vs Specialty Chemicals peers Updated Oct 22, 2026Return on Assets (TTM)
-1.50%vs Specialty Chemicals peers Updated Oct 22, 2026Return on Equity (TTM)
-9.84%vs Specialty Chemicals peers Updated Oct 22, 2026Revenue (TTM)
2.52BCNY378.15M · vs all stocks (USD) Updated Oct 22, 2026Revenue per Share (TTM)
3.81CNYUpdated Oct 22, 2026Quarterly Revenue Growth
10.60%vs Specialty Chemicals peers Updated Oct 22, 2026Gross Profit (TTM)
42.68MCNY6.40M · vs all stocks (USD) Updated Oct 22, 2026EBITDA (TTM)
6.24MCNY935.60K · vs all stocks (USD) Updated Oct 22, 2026Net Income (TTM)
-163.12MCNY-24.46M · vs all stocks (USD) Updated Oct 22, 2026Quarterly Earnings Growth (YoY)
10.55%vs Specialty Chemicals peers Updated Oct 22, 2026Operating Cash Flow (TTM)
-63.26MCNY-9.48M · vs all stocks (USD) Updated Oct 22, 2026Levered Free Cash Flow (TTM)
-984.79MCNY-147.65M · vs all stocks (USD) Updated Oct 22, 20265-Year Average Dividend Yield
0.52%Updated Oct 22, 2026Payout Ratio
100.00%vs Specialty Chemicals peers Updated Oct 22, 2026Revenue
2.46BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.39BCNYFY2025 · Dec 31, 2025Gross Profit
64.89MCNYFY2025 · Dec 31, 2025Operating Income
-64.58MCNY-9.68M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-167.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
-13.93MCNYFY2025 · Dec 31, 2025Net Income
-153.41MCNYFY2025 · Dec 31, 2025EBIT
-163.02MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.24MCNYFY2025 · Dec 31, 2025Research & Development
8.88MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
30.64MCNYFY2025 · Dec 31, 2025Other Operating Expenses
16.95MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.32MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
697.33MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
697.33MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-153.41MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-262.51MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.10BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
322.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-153.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-114.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
1.78MCNYFY2025 · Dec 31, 2025Capital Expenditures
-833.01MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.13BCNYFY2025 · Dec 31, 2025Sale of Investments
1.14BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-823.28MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
680.07MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-213.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-7.71MCNYFY2025 · Dec 31, 2025Other Financing Charges
121.11MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
579.98MCNYFY2025 · Dec 31, 2025